Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Jens Aastrup ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   0.9% 5.0% 4.3% 2.4% 5.6% 4.6% 9.0% 9.0%   Credit score (0-100)   90 45 48 62 40 45 27 27   Credit rating   A BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   305.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,123 4,354 4,854 5,340 5,228 5,335 0.0 0.0   EBITDA   756 -194 285 826 686 499 0.0 0.0   EBIT   383 -594 -142 390 232 18.4 0.0 0.0   Pre-tax profit (PTP)   1,910.0 -1,017.9 -377.8 281.5 60.4 -180.0 0.0 0.0   Net earnings   1,906.5 -775.0 -300.7 209.4 34.9 -149.8 0.0 0.0   Pre-tax profit without non-rec. items   1,910 -1,018 -378 281 60.4 -180 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,291 2,177 2,146 2,064 1,782 1,667 0.0 0.0   Shareholders equity total   2,987 1,812 1,011 821 174 -34.5 -84.5 -84.5   Interest-bearing liabilities   1,917 598 1,311 1,280 1,507 1,481 1,143 1,143   Balance sheet total (assets)   7,157 4,310 4,087 3,943 3,318 3,012 1,059 1,059   Net Debt   1,860 513 1,300 1,244 1,504 1,476 1,143 1,143     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,123 4,354 4,854 5,340 5,228 5,335 0.0 0.0   Gross profit growth   32.5% -15.0% 11.5% 10.0% -2.1% 2.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,157 4,310 4,087 3,943 3,318 3,012 1,059 1,059   Balance sheet change%   41.0% -39.8% -5.2% -3.5% -15.8% -9.2% -64.9% 0.0%   Added value   755.6 -194.4 285.0 825.7 667.5 498.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   29 -609 -555 -614 -832 -691 -1,667 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.5% -13.6% -2.9% 7.3% 4.4% 0.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.9% -8.1% -5.8% 10.4% 6.5% 0.7% 0.0% 0.0%   ROI %   56.8% -11.8% -9.8% 18.0% 11.5% 1.2% 0.0% 0.0%   ROE %   83.5% -32.3% -21.3% 22.9% 7.0% -9.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.7% 42.0% 24.7% 20.8% 5.2% -1.1% -7.4% -7.4%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   246.1% -263.7% 456.0% 150.6% 219.3% 296.0% 0.0% 0.0%   Gearing %   64.2% 33.0% 129.7% 156.0% 865.1% -4,293.6% -1,353.1% -1,353.1%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   29.2% 44.0% 14.2% 10.4% 12.5% 13.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.2 0.2 0.1 0.1 0.0 0.0   Current Ratio   0.2 0.3 0.2 0.2 0.1 0.1 0.0 0.0   Cash and cash equivalent   57.6 85.1 11.8 36.8 2.5 4.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,083.8 -1,685.0 -2,435.2 -2,375.2 -2,639.1 -2,667.6 -571.6 -571.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   756 -194 285 826 668 499 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   756 -194 285 826 686 499 0 0   EBIT / employee   383 -594 -142 390 232 18 0 0   Net earnings / employee   1,906 -775 -301 209 35 -150 0 0